unknown
Stage
1
Investors
About
Intelliseq develops the cloud-based iFlow platform for automated analysis and clinical interpretation of genomic (NGS) data, and offers GeneSpect modules for hereditary, somatic, pharmacogenomics (PGx) and polygenic risk score (PRS) reporting.
Explore Intelliseq's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.